Phio Pharmaceuticals
| Region | Nordamerika |
| ISIN | US71880W2044 |
| Sektor | Biotechnologie |
| Website | http://www.phiopharma.com |
Phio Pharmaceuticals is focused on developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYLTM) therapeutic platform. Immunotherapies harness our immune system to restore surveillance of tumors that evade detection – a potential curative medicine. INTASYLTM therapeutics can be used as a standalone treatment or in combination with other modalities.
| Titel | Autor | Datum |
|---|---|---|
|
In Wahrheit 100 Mal so viel wert?
|
sharedeals | vor über 5 Jahren |
| Titel | Datum |
|---|---|
| MOL, MISC and PETRONAS form joint venture to advance cross-border CO2 transportation | vor 13 Tagen |
| Petronas, MISC and MOL debut LCO2 carrier JV | vor 13 Tagen |
| PETRONAS, MISC, MOL ink JV to Pioneer CO2 Transport | vor 13 Tagen |
| Bursa, RHB, Hong Leong Bank, Axiata, MISC, IOI Properties, TM, GenP, Kerjaya Prospek, Sime Darby Property, 7-Eleven Malaysia, AAX, Pestec... | vor ungefähr einem Monat |
| MISC's 1Q net profit falls 7%, declares eight sen dividend | vor ungefähr einem Monat |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| PayPal (1 Artikel) | |
| Palatin Technologies (4 Artikel) | |
| Premier Gold Mines (1 Artikel) | |
| QIAGEN (1 Artikel) | |
| Alle anzeigen | |